ACE2 and depressive symptom measurement: In the first (22)) the authors emphasize parallel pathways of kynurenine (KYN) pathway activation by COVID-19 cytokine storm and angiotensin-converting enzyme 2 (ACE2) receptor effects in increased risk for depression.